What is the incidence rate of germline alterations in CDH1, which has been reported as a susceptibility gene present in 25% to 50% of patients with hereditary diffuse gastric cancer (HDGC), and is there a genetic basis underlying disease susceptibility in the remaining 50% to 75% of patients with HDGC? The gene discussed is CDH1; the disease is Familial gastric cancer.